Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study.
Gupta S, Biswas G, Babu S, Maksud TM, Lakshmaiah KC, Patel JG, Raja G, Boya RR, Patil P, Choudhury K, Bondarde SA, Neve RS, Bhat G, Mamillapalli G, Patel AA, Patel P, Joshi N, Bajaj V, Khan MA. Gupta S, et al. Among authors: biswas g. Breast. 2021 Dec;60:147-154. doi: 10.1016/j.breast.2021.09.012. Epub 2021 Oct 1. Breast. 2021. PMID: 34624757 Free PMC article. Clinical Trial.
Scleroderma and dermographism in a case of carcinoma ovary.
Vottery R, Biswas G, Deshmukh C, Gupta S, Nair R, Parikh P. Vottery R, et al. Among authors: biswas g. Indian J Dermatol Venereol Leprol. 2005 Nov-Dec;71(6):429-30. doi: 10.4103/0378-6323.18953. Indian J Dermatol Venereol Leprol. 2005. PMID: 16394490 No abstract available.
Cytomegalovirus oesophagitis in a patient with Non-Hodgkin's lymphoma.
Hingmire SS, Biswas G, Bakshi A, Desai S, Dighe S, Nair R, Gupta S, Parikh PM. Hingmire SS, et al. Among authors: biswas g. Indian J Med Microbiol. 2008 Jan-Mar;26(1):79-80. doi: 10.4103/0255-0857.38866. Indian J Med Microbiol. 2008. PMID: 18227606
A Prospective, Randomized, Multiple-Dose, Multi-Center, Comparative Clinical Study to Evaluate the Efficacy, Safety, Immunogenicity of a biosimilar Bevacizumab (Test product, Hetero) and Reference Medicinal Product (Bevacizumab, Roche) in Patients of Metastatic Colorectal Cancer.
Advani S, Biswas G, Sinha S, B B, Bandi VK, Naidu N, Thakur P, Chary S. Advani S, et al. Among authors: biswas g. J Assoc Physicians India. 2018 Jun;66(6):55-59. J Assoc Physicians India. 2018. PMID: 31331137 Clinical Trial.
338 results